文献速递心境障碍精神分裂症与精神病性障碍物质与行为成瘾

超越遗传:精神障碍风险与保护因素的循证图谱

Risk and protective factors for mental disorders beyond genetics: an evidence-based atlas.
PubMed 文献 · World Psychiatry · 2021-01-01

该研究对伞状综述进行「元-伞状」系统综合,检索截至2021年1月1日的国际数据库,纳入14篇伞状综述,汇总390项meta分析和1180个关联。研究识别出176个I-III级证据关联,涉及142个风险/保护因素,其中21个最稳健的风险因素和1个保护因素。

要点

  • 最稳健风险因素涉及痴呆、阿片使用障碍、精神病性障碍、抑郁、孤独症和ADHD等。
  • 仅发现一个稳健保护因素:高体力活动对阿尔茨海默病(HR=0.62)。
  • 32.9%的关联为高质量证据,48.9%为中等质量,18.2%为低质量。

核心结论

  • 研究构建了超越遗传的精神障碍关键风险与保护因素循证图谱,为临床表征、研究和早期干预提供基准。

研究设计与样本

  • 对伞状综述进行「元-伞状」系统综合,检索国际数据库从建库至2021年1月1日。
  • 纳入14篇伞状综述,汇总390项meta分析和1180个风险/保护因素与精神障碍的关联。
  • 采用I-IV级证据可信度分类,并进行前瞻性研究敏感性分析、TRANSD跨诊断标准测试和AMSTAR质量评估。

主要发现

  • 纳入176个I-III级证据关联,涉及142个风险/保护因素,其中21个最稳健风险因素(I或II级,来自前瞻性设计)。
  • 痴呆最稳健风险因素包括2型糖尿病(RR 1.54-2.28)、抑郁(RR 1.65-1.99)和社交接触频率低(RR=1.57)。
  • 阿片使用障碍最稳健风险因素为吸烟(OR=3.07);非器质性精神病性障碍为临床高风险状态(OR=9.32)、大麻使用(OR=3.90)和童年逆境(OR=2.80)。
  • 抑郁障碍最稳健风险因素包括丧偶(RR=5.59)、性功能障碍(OR=2.71)、3个(OR=1.99)或4-5个(OR=2.06)代谢因素、童年身体(OR=1.98)和性(OR=2.42)虐待、工作紧张(OR=1.77)、肥胖(OR=1.35)和睡眠障碍(RR=1.92)。
  • 孤独症谱系障碍最稳健风险因素为孕前/孕期母亲超重(RR=1.28);ADHD为孕前母亲肥胖(OR=1.63)、孕期母亲吸烟(OR=1.60)和孕前/孕期母亲超重(OR=1.28)。

关键数值与推荐

  • 证据可信度分类:I级(令人信服)、II级(高度提示)、III级(提示性)、IV级(弱)。
  • 仅一个稳健保护因素:高体力活动对阿尔茨海默病(HR=0.62)。
  • 32.9%的关联为高质量,48.9%为中等质量,18.2%为低质量。
  • 跨诊断I-III级风险/保护因素大多涉及早期神经发育期。

临床怎么用

  • 临床可参考本图谱中的稳健风险因素进行风险评估和早期识别。
  • 针对可干预因素(如代谢因素、吸烟、大麻使用、童年逆境、睡眠障碍、体力活动)制定预防和干预策略。
  • 跨诊断因素提示早期神经发育期是预防干预的关键窗口。

局限性

  • 证据质量不一,仅32.9%的关联为高质量。
  • 部分关联可能受反向因果影响,虽经前瞻性设计敏感性分析但未完全排除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Decades of research have revealed numerous risk factors for mental disorders beyond genetics, but their consistency and magnitude remain uncer-tain. We conducted a "meta-umbrella" systematic synthesis of umbrella reviews, which are systematic reviews of meta-analyses of individual studies, by searching international databases from inception to January 1, 2021. We included umbrella reviews on non-purely genetic risk or protective factors for any ICD/DSM mental disorders, applying an established classification of the credibility of the evidence: class I (convincing), class II (highly suggestive), class III (suggestive), class IV (weak). Sensitivity analyses were conducted on prospective studies to test for temporality (reverse causation), TRANSD criteria were applied to test transdiagnosticity of factors, and A Measurement Tool to Assess Systematic Reviews (AMSTAR) was employed to address the quality of meta-analyses. Fourteen eligible umbrella reviews were retrieved, summarizing 390 meta-analyses and 1,180 associations between putative risk or protective factors and mental disorders. We included 176 class I to III evidence associations, relating to 142 risk/protective factors. The most robust risk factors (class I or II, from prospective designs) were 21. For dementia, they included type 2 diabetes mellitus (risk ratio, RR from 1.54 to 2.28), depression (RR from 1.65 to 1.99) and low frequency of social contacts (RR=1.57). For opioid use disorders, the most robust risk factor was tobacco smoking (odds ratio, OR=3.07). For non-organic psychotic disorders, the most robust risk factors were clinical high risk state for psychosis (OR=9.32), cannabis use (OR=3.90), and childhood adversities (OR=2.80). For depressive disorders, they were widowhood (RR=5.59), sexual dysfunction (OR=2.71), three (OR=1.99) or four-five (OR=2.06) metabolic factors, childhood physical (OR=1.98) and sexual (OR=2.42) abuse, job strain (OR=1.77), obesity (OR=1.35), and sleep disturbances (RR=1.92). For autism spectrum disorder, the most robust risk factor was maternal overweight pre/during pregnancy (RR=1.28). For attention-deficit/hyperactivity disorder (ADHD), they were maternal pre-pregnancy obesity (OR=1.63), maternal smoking during pregnancy (OR=1.60), and maternal overweight pre/during pregnancy (OR=1.28). Only one robust protective factor was detected: high physical activity (hazard ratio, HR=0.62) for Alzheimer's disease. In all, 32.9% of the associations were of high quality, 48.9% of medium quality, and 18.2% of low quality. Transdiagnostic class I-III risk/protective factors were mostly involved in the early neurodevelopmental period. The evidence-based atlas of key risk and protective factors identified in this study represents a benchmark for advancing clinical characterization and research, and for expanding early intervention and preventive strategies for mental disorders.

来源:World Psychiatry,查看原文。版权归原作者所有。

引用

  1. Arango C, Dragioti E, Solmi M, et al. Risk and protective factors for mental disorders beyond genetics: an evidence-based atlas. World Psychiatry. 2021. PMID: 34505386. doi:10.1002/wps.20894

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。